Overexpression of ATF5 promotes anoikis resistance in vitro and in vivo. A and B, ATF5 overexpression, by immunoblot, in suspension culture of BE(2)-C and SH-SY5Y cells, 72 hours after transient transfection with pCCL-GFP or pCCL-ATF5. ACTB was used as a loading control. Densitometric analysis was performed using ImageJ. C and D, BE(2)-C and SH-SY5Y suspension cell viability and anoikis at 12, 24, 48, and 72 hours after transfection, respectively. At each timepoint, the comparison is between cells overexpressing ATF5 and control cells expressing GFP (100%). Mean ± SD. E, Quantification of mouse whole-body bioluminescence flux (photons/second) 12 hours after intracardiac injection of BE(2)-C cells overexpressing ATF5 (n = 8) or GFP (n = 7). ...
Supplementary Figure 9 shows that BMF knockdown rescues ATF5 loss-induced reduction of anchorage-ind...
Supplementary Figure 16 shows that CP-d/n-ATF5 inhibits growth of BE(2)-C tumors and increases apopt...
Supplementary Figure 6 shows a decrease in ATF5 after Dox addition under non-adherent suspension con...
CP-d/n-ATF5 induces anoikis and inhibits neuroblastoma growth and metastasis in vivo. A, Effects of ...
Depletion of ATF5 induces anoikis and decreases metastasis of neuroblastoma cells. A and B, Viabilit...
BMF is required for ATF5 depletion–dependent anoikis induction and is upregulated by FOXO3 induction...
ATF5 depletion induces BMF in suspension culture. Immunoblot of BCL-2 family proteins in BE(2)-C cel...
Elevated ATF5 expression correlates with poor outcomes in patients with neuroblastoma, and ATF5 sile...
Supplementary Figure 2 shows that ATF5 knockdown decreases neuroblastoma cell viability and promotes...
Supplementary Figure 4 shows that decreased ATF5 expression does not alter the invasiveness of BE(2)...
Supplementary Figure 1 shows that ATF5 is expressed in neuroblastoma cell lines.</p
Supplementary Figure 5 shows that overexpression of ATF5 promotes anoikis resistance of CHLA-255 in ...
Supplementary Figure 14 shows that CP-d/n-ATF5 induces anoikis of neuroblastoma cell lines</p
Supplementary Figure 18 shows that CP-d/n-ATF5 treatment decreased viability and induced anoikis of ...
Supplementary Figure 7 shows that ATF5 knockdown decreases SK-N-DZ CTC survival</p
Supplementary Figure 9 shows that BMF knockdown rescues ATF5 loss-induced reduction of anchorage-ind...
Supplementary Figure 16 shows that CP-d/n-ATF5 inhibits growth of BE(2)-C tumors and increases apopt...
Supplementary Figure 6 shows a decrease in ATF5 after Dox addition under non-adherent suspension con...
CP-d/n-ATF5 induces anoikis and inhibits neuroblastoma growth and metastasis in vivo. A, Effects of ...
Depletion of ATF5 induces anoikis and decreases metastasis of neuroblastoma cells. A and B, Viabilit...
BMF is required for ATF5 depletion–dependent anoikis induction and is upregulated by FOXO3 induction...
ATF5 depletion induces BMF in suspension culture. Immunoblot of BCL-2 family proteins in BE(2)-C cel...
Elevated ATF5 expression correlates with poor outcomes in patients with neuroblastoma, and ATF5 sile...
Supplementary Figure 2 shows that ATF5 knockdown decreases neuroblastoma cell viability and promotes...
Supplementary Figure 4 shows that decreased ATF5 expression does not alter the invasiveness of BE(2)...
Supplementary Figure 1 shows that ATF5 is expressed in neuroblastoma cell lines.</p
Supplementary Figure 5 shows that overexpression of ATF5 promotes anoikis resistance of CHLA-255 in ...
Supplementary Figure 14 shows that CP-d/n-ATF5 induces anoikis of neuroblastoma cell lines</p
Supplementary Figure 18 shows that CP-d/n-ATF5 treatment decreased viability and induced anoikis of ...
Supplementary Figure 7 shows that ATF5 knockdown decreases SK-N-DZ CTC survival</p
Supplementary Figure 9 shows that BMF knockdown rescues ATF5 loss-induced reduction of anchorage-ind...
Supplementary Figure 16 shows that CP-d/n-ATF5 inhibits growth of BE(2)-C tumors and increases apopt...
Supplementary Figure 6 shows a decrease in ATF5 after Dox addition under non-adherent suspension con...